Invictus RG’s Amphastar Pharmaceuticals AMPH Stock Holding History

Invictus RG’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,950	Closed	-$220K	–	692
2016 Q4	$220K	Buy	+11,950	New	+$232K	0.15%	287

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invictus RG's AMPH Position: Q1 2017 in Review

Invictus RG sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2017, closing a stake of 11,950 shares — an estimated $220K sold.

Invictus RG first reported a position in AMPH in Q4 2016 and held it in 1 quarter. The position peaked at $220K in Q4 2016. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2017.

Invictus RG reported no remaining Amphastar Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Invictus RG sold 11,950 Amphastar Pharmaceuticals shares in Q1 2017, an estimated $220K.
Invictus RG first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 1 quarter.
Invictus RG's Amphastar Pharmaceuticals position peaked at $220K in Q4 2016.
116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2017.

Based on Invictus RG's 13F filing for Q1 2017, filed 12 May 2017.